What is the main business of Sonux?

The main business activity of Sonux focuses on research and experimental development in natural sciences and engineering.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 26, 2023.

Where is the headquarters located?

The headquarters is located at: Odeska 11, 51-205 Wrocław.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of USD 5, representing a decrease of 3.0% compared to 2024.

No, the company recorded a net loss of USD 8,605 in 2025. For comparison, in 2024 the loss was USD 2,466, meaning the company increased its loss by 248.2%.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to USD 8,516 in 2025, representing 99% of all operating expenses.

Sonuxsp. z o.o.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status

Suspended

Registry date

2023-06-26

Share capital

5,000.00 PLN

Registered address

Odeska 11, 51-205 Wrocław, Poland

Electronic delivery address

AE:PL-11474-37293-UWFUE-23

Financials

Revenue history

Filing timeliness

2 of 3 financial statements were filed late (the longest delay 470 days for 2023).

202506/05/2026
202428/10/2025
202328/10/2025

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 4.87MedianUSD 152.85kAverageUSD 4.86m

Net profit

This companyUSD -8.61kMedianUSD -228.23AverageUSD 317.06k

Operating costs

This companyUSD 8.61kMedianUSD 187.91kAverageUSD 4.67m

Assets

This companyUSD 148.58MedianUSD 278.35kAverageUSD 8.47m

Industry

Authorized Representatives

Hope Elizabeth Bass – President of the Management Board

Maciej Laszczyk – Management Board Member

Manner of representation

Each member of the management board is authorized to submit declarations of will on behalf of the company and to represent it externally independently.

Ownership

Owner	Shares	Share value	Stake
Biomedical Music Solutions, Inc.	89	$1,202.05	89%
Maciej Laszczykage 35	11	$148.57	11%

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

	Name	Revenue	Website
	Genovaris Medicalsp. z o.o.	$25.11	genovaris.com
	Spectrace Echosp. z o.o.	$0.61	spectrace.pl

Change history

Date	Event
2026-10-01	Business suspended
2026-05-08	Address change (Ul. Jagodowa 8, 20-141, Lublin → Odeska 11, 51-205, Wrocław)
2024-10-18	Name change (Biomedical Music Solutions → Sonux)
2023-06-26	Entered in the register

FAQ

Last updated: 2026-10-03